-
CTNPT 005: Measuring cognition in HIV
Measuring cognitive decline in patients at high risk for developing HIV-related neurocognitive dysfunction
-
CTN 277: CARMA endo study
Endocrinopathy u0026 cellular aging in women and girls enrolled in the CARMA cohort
-
CTN 289: E/C/F/TAF switch with ledipasivir-sofosbuvir therapy
Evaluation of E/C/F/TAF switch followed by ledipasivir-sofosbuvir antiviral HCV therapy in HIV-HCV co-infection
-
-
-
CTN 284: WelTel Retain
Promoting Engagement in Pre-ART HIV Care Through SMS Patient retention in care (continuing to see their medical professional) and adherence to treatment (following the treatment program) leads to better health outcomes for patients and is important to the success of HIV care programs. Unfortunately, many patients do not consistently remain in care. Furthermore, low-income settings…
-
CTNPT 013: Sexual health and HIV-risk management in MSM
The impact of in-clinic follow-up with a sexologist on the sexual health of HIV-serodiscordant MSM couples
-
-
CTN 239: Phase II study of AGS-004 an immunotherapeutic agent in combination with ART followed by ART interruption
A phase II study testing the activity and safety of AGS-004 as an immunotherapeutic in successfully ART-treated subjects infected with HIV-1 in combination with ART followed by ART interruption: Trial results
-
CTN 268: ANRS IPERGAY trial
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
-
CTN 229: Effect of AGS-004 immunotherapeutic agent in HIV-positive people on HAART
A pilot study (Phase I/II) testing the immunologic activity and safety of AGS-004, an autologous HIV immunotherapeutic, in HIV-infected adults on HAART: Trial results
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More